While VEGF and VEGFR play an essential role in ovarian cancer progression, recent studies have shown that promoters of angiogenesis such as angiopoietins, apelin receptors, and its ligand apelin, NR4A2, also play an equally important role. This evidence concerns the gene APLN and ovarian cancer.